Late thrombosis of percutaneous aortic valve prosthesis in a patient with cancer. Case report
DOI:
https://doi.org/10.37615/retic.v6n1a5Keywords:
percutaneous aortic valve replacement, thrombosis, neoplasiaAbstract
Clinical or symptomatic thrombosis after transcatheter aortic valve replacement (TAVR) is rare and typically occurs in less than 1 % of implanted patients, however when it does occur it is associated with serious complications including stroke, cardiogenic shock, and death. We present the case of a patient with a percutaneous prosthesis and a history of neoplasia, who presented an event of prosthetic thrombosis, requiring in-hospital management. The objective of this case is to show that the incidence of prosthetic valve thrombosis after TAVR remains an unresolved issue, which is facing us with new diagnostic challenges.
Downloads
Metrics
References
Jose J, Sulimov DS, El-Mawardy M, Sato T, Allali A, Holy EW, Becker B, Landt M, Kebernik J, Schwarz B, Richardt G, Abdel-Wahab M. Clinical bioprosthetic heart valve thrombosis after transcatheter aortic valve replacement: incidence, characteristics, and treatment outcomes. JACC Cardiovasc Interv. 2017; 10:686–697. doi: https://doi.org/10.1016/j.jcin.2017.01.045 DOI: https://doi.org/10.1016/j.jcin.2017.01.045
Makkar RR, Fontana G, Jilaihawi H, Chakravarty T, Kofoed KF, De Backer O, Asch FM, Ruiz CE, Olsen NT, Trento A, Friedman J, Berman D, Cheng W, Kashif M, Jelnin V, Kliger CA, Guo H, Pichard AD, Weissman NJ, Kapadia S, Manasse E, Bhatt DL, Leon MB, Søndergaard L. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med. 2015;373:2015– 2024. doi: https://doi.org/10.1056/NEJMoa1509233 DOI: https://doi.org/10.1056/NEJMoa1509233
Pache G, Schoechlin S, Blanke P, Dorfs S, Jander N, Arepalli CD, Gick M, Buettner HJ, Leipsic J, Langer M, Neumann FJ, Ruile P. Early hypo-attenuated leaflet thickening in balloon expandable transcatheter aortic heart valves. Eur Heart J. 2016; 37:2263–2271. doi:https://doi.org/10.1093/eurheartj/ehv526 DOI: https://doi.org/10.1093/eurheartj/ehv526
Egbe AC, Pislaru SV, Pellikka PA, Poterucha JT, Schaff HV, Maleszewski JJ, Connolly HM. Bioprosthetic valve thrombosis versus structural failure: clinical and echocardiographic predictors. J Am Coll Cardiol. 2015; 66:2285– 2294. doi: https://doi.org/10.1016/j.jacc.2015.09.022 DOI: https://doi.org/10.1016/j.jacc.2015.09.022
Mylotte D, Andalib A, Thériault-Lauzier P, Dorfmeister M, Girgis M, Alharbi W, Chetrit M, Galatas C, Mamane S, Sebag I, Buithieu J, Bilodeau L, de Varennes B, Lachapelle K, Lange R, Martucci G, Virmani R, Piazza N. Transcatheter heart valve failure: a systematic review. Eur Heart J. 2015 Jun 1;36(21):1306-27. doi: https://doi.org/10.1093/eurheartj/ehu388 Epub 2014 Sep 28. PMID: 25265974 DOI: https://doi.org/10.1093/eurheartj/ehu388
Paneesha S, McManus A, Arya R, Scriven N, Farren T, Nokes T, Bacon S, Nieland A, Cooper D, Smith H, O’Shaughnessy D, Rose P; VERITY Investigators. Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at outpatient DVT clinics. Thromb Haemost. 2010 Feb;103(2):338-43. doi:https://doi.org/10.1160/TH09-06-0397 Epub 2009 Dec 18. PMID: 20024496 DOI: https://doi.org/10.1160/TH09-06-0397
Pibarot P, Herrmann HC, Wu C, Hahn RT, Otto CM, Abbas AE, Chambers J, Dweck MR, Leipsic JA, Simonato M, Rogers T, Sathananthan J, Guerrero M, Ternacle J, Wijeysundera HC, Sondergaard L, Barbanti M, Salaun E, Généreux P, Kaneko T, Landes U, Wood DA, Deeb GM, Sellers SL, Lewis J, Madhavan M, Gillam L, Reardon M, Bleiziffer S, O’Gara PT, Rodés-Cabau J, Grayburn PA, Lancellotti P, Thourani VH, Bax JJ, Mack MJ, Leon MB; Heart Valve Collaboratory. Standardized Definitions for Bioprosthetic Valve Dysfunction Following Aortic or Mitral Valve Replacement: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022 Aug2;80(5):545-561. doi: https://doi.org/10.1016/j.jacc.2022.06.002 PMID: 35902178 DOI: https://doi.org/10.1016/j.jacc.2022.06.002
Dangas GD, Weitz JI, Giustino G, Makkar R, Mehran R. Prosthetic Heart Valve Thrombosis. J Am Coll Cardiol. 2016 Dec 20;68(24):2670-2689. doi: https://doi.org/10.1016/j.jacc.2016.09.958 PMID: 27978952 DOI: https://doi.org/10.1016/j.jacc.2016.09.958
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Julio Cesar Rivera Hermosillo, Jesús Samuel Borges López, Fernando Iván Vergara Orduña, Luis Erik Olivares Sánchez, Lizbeth Moreno Cuevas
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
RETIC is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license https://creativecommons.org/licenses/by-nc-nd/4.0 which allows sharing, copying and redistribution of the material in any medium or format, under the following terms:
- Attribution: you must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests that the licensor endorses you or your use.
- Non-commercial: you may not use the material for commercial purposes.
- No Derivatives: if you remix, transform or build upon the material, you may not distribute the modified material.
- No Additional Restrictions: you may not apply legal terms or technological measures that legally restrict others from doing anything permitted by the license.
